Metabolites (Jan 2023)

Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD

  • Lingxuan An,
  • Ulrich Wirth,
  • Dominik Koch,
  • Malte Schirren,
  • Moritz Drefs,
  • Dionysios Koliogiannis,
  • Hanno Niess,
  • Joachim Andrassy,
  • Markus Guba,
  • Alexandr V. Bazhin,
  • Jens Werner,
  • Florian Kühn

DOI
https://doi.org/10.3390/metabo13010101
Journal volume & issue
Vol. 13, no. 1
p. 101

Abstract

Read online

Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver disease, ranging from simple steatosis to hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Liver fibrosis, which portends a poor prognosis in NAFLD, is characterized by the excessive accumulation of extracellular matrix (ECM) proteins resulting from abnormal wound repair response and metabolic disorders. Various metabolic factors play crucial roles in the progression of NAFLD, including abnormal lipid, bile acid, and endotoxin metabolism, leading to chronic inflammation and hepatic stellate cell (HSC) activation. Autophagy is a conserved process within cells that removes unnecessary or dysfunctional components through a lysosome-dependent regulated mechanism. Accumulating evidence has shown the importance of autophagy in NAFLD and its close relation to NAFLD progression. Thus, regulation of autophagy appears to be beneficial in treating NAFLD and could become an important therapeutic target.

Keywords